Specialist sourcing. A focused purpose.

Medicines supply is our focus.

AstraNova is a Crownbridge Group enterprise with an initial commercial focus on selected hard-to-source hospital medicines and supply continuity. We are building around precise buyer requirements, qualified source relationships and disciplined supply commitments.

With a United Kingdom foundation and a global outlook, we are developing international relationships around destination-specific requirements and the needs of healthcare organisations worldwide.

Professional service, from the first conversation.

We begin with the supply problem: a medicine unavailable through usual channels, a recurring supply difficulty, an unavailable presentation or a specialist sourcing requirement. We define the exact product, presentation, volume, destination and handling conditions. We then assess supplier suitability, customer eligibility and the practical route to fulfilment.

A focused scientific ambition.

AstraNova Research & Translational Sciences is our research unit focused on AI drug discovery, medicines security and pharmacovigilance. The unit is launching with a defined programme agenda, project briefs and governance requirements. Completed findings, appointments and confirmed partnerships will be reported as they are established.

People remain accountable.

AstraNova uses LUMIRAX to support its operations. Our customer proposition remains pharmaceutical wholesale distribution, with professional responsibility for sourcing, service and quality decisions.